hemodialysis
Conditions
Interventions
Furosemide treatment group:Furosemide treatment
Control group:Blank control
Sponsors
Department of Nephrology, West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Participants who have been treated with HD three times a week for more than 3 months, medically stable, with residual renal function (RRF) of more than 200 ml urine output per day (based on a 24-hour urine collection, measured by a 200 ml measuring cup), and consent to participate in the study.
Exclusion criteria
Exclusion criteria: Participants with systolic blood pressure <= 100mmHg, a history of liver cirrhosis or concurrent liver impairment, experienced congestive heart failure (ejection fraction <= 50%), acute myocardial infarction or stroke in the preceding six months; used loop diuretics in the preceding one month; plan to receive a kidney transplant during the study period, or any other condition that the research staff judged as hard to complete, or comply with, or otherwise unsuitable for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the rate of symptomatic IDH; | — |
Secondary
| Measure | Time frame |
|---|---|
| Admission rate;All cause mortality;Cardiac mortality;Cardiovascular events;Episode of frank (or suspected) sepsis;Interdialytic weight gain;IDH-related nursing interventions; | — |
Countries
China
Contacts
Public ContactZhang Ling
Sichuan University West China Hospital
Outcome results
None listed